- Home
- MRNA vs ULS Comparison
MRNA vs ULS Comparison
Compare MRNA & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- ULS
- Stock Information
- Founded
- MRNA 2010
- ULS 1894
- Country
- MRNA United States
- ULS United States
- Employees
- MRNA N/A
- ULS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- ULS
- Sector
- MRNA Health Care
- ULS
- Exchange
- MRNA Nasdaq
- ULS Nasdaq
- Market Cap
- MRNA 13.4B
- ULS 14.6B
- IPO Year
- MRNA 2018
- ULS 2024
- Fundamental
- Price
- MRNA $28.02
- ULS $67.16
- Analyst Decision
- MRNA Hold
- ULS Buy
- Analyst Count
- MRNA 20
- ULS 8
- Target Price
- MRNA $46.24
- ULS $69.25
- AVG Volume (30 Days)
- MRNA 8.6M
- ULS 1.0M
- Earning Date
- MRNA 08-01-2025
- ULS 08-05-2025
- Dividend Yield
- MRNA N/A
- ULS 0.77%
- EPS Growth
- MRNA N/A
- ULS 21.42
- EPS
- MRNA N/A
- ULS 1.62
- Revenue
- MRNA $3,078,000,000.00
- ULS $2,951,000,000.00
- Revenue This Year
- MRNA N/A
- ULS $6.76
- Revenue Next Year
- MRNA $10.04
- ULS $6.04
- P/E Ratio
- MRNA N/A
- ULS $41.50
- Revenue Growth
- MRNA N/A
- ULS 6.92
- 52 Week Low
- MRNA $23.15
- ULS $46.79
- 52 Week High
- MRNA $91.99
- ULS $74.15
- Technical
- Relative Strength Index (RSI)
- MRNA 46.33
- ULS N/A
- Support Level
- MRNA $25.30
- ULS N/A
- Resistance Level
- MRNA $27.08
- ULS N/A
- Average True Range (ATR)
- MRNA 1.33
- ULS 0.00
- MACD
- MRNA -0.31
- ULS 0.00
- Stochastic Oscillator
- MRNA 32.38
- ULS 0.00
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.